Search for: "Hospira" Results 81 - 100 of 487
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Apr 2012, 4:00 pm by Courtenay Brinckerhoff
Hospira, Inc., the Federal Circuit upheld the district court’s finding that two of the Orange Book listed patents for Sanofi Aventis’ cancer drug Taxotere are unenforceable for inequitable conduct. [read post]
26 Jun 2017, 11:27 am by Jay W. Belle Isle
Over concerns of sterility, Hospira Inc., a Pfizer company, has voluntarily recalled three injectable products, as of June 15, 2017. [read post]
13 Jul 2015, 10:00 pm by Courtenay C. Brinckerhoff
Hospira, Inc., the Federal Circuit held that a transaction with a contract manufacturer gave rise to an on sale bar that invalidated The Medicines Company’s Angiomax® patents. [read post]
12 Dec 2008, 4:35 am
Hospira, a global medication delivery company, is voluntarily recalling a plastic product used to administer injections. [read post]
6 Jan 2008, 9:07 pm
Hospira, Inc. 2:07-cv-08137; filed December 14, 2007 in the Central District of California... [read post]
28 Jul 2010, 7:50 am by Theo Francis
Yet it seems to be very real at Hospira (HSP), the specialty pharmaceutical supplier to hospitals, clinics, nursing homes and other institutions. [read post]
21 Jan 2011, 11:52 am by Kent Scheidegger
Hospira, the only US manufacturer of the sodium thiopental used in lethal injection in most death penalty states, has decided to discontinue manufacture altogether, AP reports. [read post]
11 Oct 2018, 3:01 pm by Sara Moran
More from our authors: International Licensing Agreements: IP, Technology Transfer and Competition Law by Michala Meiselles, Hugo Wharton € 180 The Law of the European Union, Fifth Edition by eter Jan Kuijper, Fabian Amtenbrink, Deirdre Curtin, Bruno De Witte, Alison McDonnell, Stefaan van den Bogaert € 175 The post United Kingdom:… [read post]
22 Jan 2011, 4:25 am by SHG
  For Ohio, like for Hospira, it would be good business. [read post]
12 Dec 2016, 7:15 am by Brian Cordery
Brian CorderyBristowsby Chloe Dickson On 30 November 2016 the Court of Appeal handed down judgment in the latest chapter of the Hospira v Genentech epic surrounding Genentech’s blockbuster drug trastuzumab (Herceptin®) (Hospira v Genentech [2016] EWCA Civ 1185). [read post]
14 Sep 2010, 3:15 pm by Mark Zamora
Symbiq One- and Two-Channel Infusers manufactured by Hospira are subject to a class 1 US Food and Drug Administration (FDA) recall because of a potential for the failure to detect air in the line at the end of an infusion. [read post]